- Market Realist•4 hours ago
Edwards Lifesciences (EW) reported falling revenue in 3Q16. Its gross profit margin fell and was reported to be ~72.8% of its total revenue, compared to ~76.2% in 2Q16.
- Investor's Business Daily•6 hours ago
As the stock market runs into headwinds, can IBD 50 member and private mortgage insurance provider Essent find cover and support ahead of Q3 earnings?
- Market Realist•6 hours ago
Edwards Lifesciences reported ~$739.4 million in total revenue in 3Q16. Of that, ~$191 million came from the company’s SHV (Surgical Heart Valve) Therapy segment.
Edwards Lifesciences Corp. (EW)
NYSE - NYSE Delayed Price. Currency in USD
|Bid||92.38 x 100|
|Ask||97.20 x 100|
|Day's Range||92.04 - 96.80|
|52wk Range||72.20 - 121.75|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||38.01|
|Avg Vol (3m)||1,476,670|
|Dividend & Yield||N/A (N/A)|